Reported Standalone quarterly numbers for Akums Drugs Pharmaceuticals are:Net Sales at Rs 328.75 crore in March 2025 up 10.19% from Rs. 298.35 crore in March 2024.
Story continues below Advertisement
Quarterly Net Profit at Rs. 27.59 crore in March 2025 up 147.68% from Rs. 57.87 crore in March 2024.
EBITDA stands at Rs. 49.77 crore in March 2025 up 246.94% from Rs. 33.87 crore in March 2024.
Akums Drugs P EPS has increased to Rs. 1.80 in March 2025 from Rs. 4.04 in March 2024.
Akums Drugs P shares closed at 581.90 on May 23, 2025 (NSE)
| Akums Drugs Pharmaceuticals | | Standalone Quarterly Results | in Rs. Cr. |
|
| Mar'25 | Dec'24 | Mar'24 | | Net Sales/Income from operations | 328.75 | 337.41 | 298.35 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 328.75 | 337.41 | 298.35 | | EXPENDITURE | | Consumption of Raw Materials | 207.06 | 206.62 | 170.53 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | 0.35 | 7.85 | 13.10 | | Power & Fuel | -- | -- | -- | | Employees Cost | 53.84 | 50.34 | 46.80 | | Depreciation | 10.09 | 10.68 | 9.09 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 49.78 | 38.56 | 128.45 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | 7.63 | 23.34 | -69.62 | | Other Income | 32.05 | 33.84 | 26.66 | | P/L Before Int., Excpt. Items & Tax | 39.68 | 57.19 | -42.96 | | Interest | 2.63 | 2.29 | 4.80 | | P/L Before Exceptional Items & Tax | 37.06 | 54.89 | -47.75 | | Exceptional Items | -- | -- | -1.29 | | P/L Before Tax | 37.06 | 54.89 | -49.04 | | Tax | 9.47 | 13.72 | 8.83 | | P/L After Tax from Ordinary Activities | 27.59 | 41.17 | -57.87 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | 27.59 | 41.17 | -57.87 | | Equity Share Capital | 30.62 | 30.62 | 28.61 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | 1.80 | 2.69 | -4.04 | | Diluted EPS | 1.80 | 2.69 | -4.04 | | EPS After Extra Ordinary | | Basic EPS | 1.80 | 2.69 | -4.04 | | Diluted EPS | 1.80 | 2.69 | -4.04 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
